PRF Technologies (PRFX) Enterprise Value (2019 - 2025)
PRF Technologies' (PRFX) quarterly Enterprise Value came in at -$3.4 million in Q4 2025, up 20.35% YoY from -$2.8 million in Q4 2024, and up 2.86% on a QoQ basis from -$3.5 million in Q2 2025.
PRF Technologies (PRFX) Enterprise Value (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 7 years of Enterprise Value data on file, last reported at -$3.4 million in Q4 2025.
- Quarterly Enterprise Value rose 20.35% year-over-year to -$3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.4 million (up 20.35% YoY) and the FY2025 annual result came in at -$3.4 million, up 20.35% from the prior year.
- Enterprise Value climbed to -$3.4 million in Q4 2025, from -$3.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2.8 million in Q2 2024 to a low of -$19.4 million in Q1 2021.
- A 5-year average of -$10.3 million and a median of -$8.6 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value slumped 3137.09% — and 2023, when it surged 55.57%.
- Tracing PRFX's Enterprise Value over 5 years: stood at -$16.5 million in 2021, then surged by 38.44% to -$10.2 million in 2022, then increased by 21.17% to -$8.0 million in 2023, then surged by 46.91% to -$4.3 million in 2024, then grew by 20.35% to -$3.4 million in 2025.
- The last three Enterprise Value figures came in at -$3.4 million (Q4 2025), -$3.5 million (Q2 2025), and -$4.3 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | -3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.39 Mn |
| Jun 30, 2025 | -3.49 Mn |
| Dec 31, 2024 | -4.26 Mn |
| Jun 30, 2024 | -2.79 Mn |
| Mar 31, 2024 | -4.33 Mn |
| Dec 31, 2023 | -8.03 Mn |
| Sep 30, 2023 | -8.59 Mn |
| Jun 30, 2023 | -6.16 Mn |
| Mar 31, 2023 | -8.15 Mn |
| Dec 31, 2022 | -10.18 Mn |
| Sep 30, 2022 | -12.98 Mn |
| Jun 30, 2022 | -13.87 Mn |
| Mar 31, 2022 | -16.57 Mn |
| Dec 31, 2021 | -16.54 Mn |
| Sep 30, 2021 | -18.34 Mn |
| Jun 30, 2021 | -17.80 Mn |
| Mar 31, 2021 | -19.44 Mn |
| Dec 31, 2020 | -15.68 Mn |
| Sep 30, 2020 | -17.72 Mn |
| Jun 30, 2020 | -550,000.00 |